Clinical Trials Update:&nbsp;Nov. 29, 2004
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
93812
The results from the new clinical trial could increase the chances that the Food and Drug Administration will approve the drug for that use.
283297
Researchers at Merck can use neural stem-cell tech in early stages of drug development. Plus: Pay for eggs OK in Britain. In Bodyhack.
668672
MONDAY, Feb. 26 (HealthDay News) -- Breast cancer treatment trials that are funded by drug companies are more likely to show positive results than studies sponsored by other sources, new research suggests.
52664
MONDAY, Oct. 18 (HealthDayNews) --The National Institute on Aging has launched a landmark study aimed at finding a way to use imaging technology to reduce the time and cost of clinical trials for Alzheimer's disease medications.
402115
Two drugs provide good results in preliminary trials.
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
727464
roundup Plus: Supercomputer center gets new No. 2...MIT, Caltech offer low-tech voting advice...Siemens builds phone to detect bad breath.
370141
FRIDAY, Jan. 11 (HealthDay News) -- Therapeutic vaccines to fight ovarian and breast cancer are in the first stage of clinical trials to determine their safety and effectiveness, researchers report.
101669
A new analysis finds that clinical trials of breast-cancer treatments by drugmakers show positive results far more often than non-industry trials. Why the difference?
603771
roundup Plus: Shopping.com holders cut IPO shares...Transmeta starts new chip, warns on earnings...Keynote to buy researcher Vividence.
383170
Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of HGS-ETR1 (agonistic human monoclonal antibody to TRAIL Receptor 1) in patients with advanced ...
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival
388692
roundup Plus: PeopleSoft-Oracle trial delayed...IBM, Boeing team up for defense work...TI touts combo chip with VoIP, Wi-Fi...ContextWeb nabs $3 million.
34476
MONDAY, July 2 (HealthDay News) -- New research may someday provide another treatment option for patients battling deadly pancreatic cancer.
644599
Pharmaceutical giant Pfizer Inc. will announce plans for a large-scale clinical trial of the ability of blockbuster drug Celebrex to prevent heart attacks and strokes in patients with
117982
Robert B. Saper, MD, MPH ; Stefanos N. Kales, MD, MPH ; Janet Paquin, PhD ; Michael J. Burns, MD ; David M. Eisenberg, MD ; Roger B. Davis, ScD ; Russell S. Phillips, MD.